The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Blocking - Blocking peptide for Anti-PHAPI2 / APRIL antibody (ab4224)
Concentration information loading...
Preparation and Storage
Stability and Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Acidic (leucine rich) nuclear phosphoprotein 32 family member B
Acidic leucine rich nuclear phosphoprotein 32 family member B
Acidic leucine-rich nuclear phosphoprotein 32 family member B
Acidic nuclear phosphoprotein 32 family member B
Acidic protein rich in leucines
Proliferation related acidic leucine rich protein
Putative HLA-DR-associated protein I-2
Silver stainable protein SSP 29
Silver stainable protein SSP29
Silver-stainable protein SSP29
Multifunctional protein working as a cell cycle progression factor as well as a cell survival factor. Required for the progression from the G1 to the S phase. Anti-apoptotic protein which functions as a caspase-3 inhibitor. Has no phosphatase 2A (PP2A) inhibitor activity (By similarity). Exhibits histone chaperone properties, stimulating core histones to assemble into a nucleosome.
Expressed in heart, lung, pancreas, prostate and in spleen, thymus and placenta.
Belongs to the ANP32 family. Contains 4 LRR (leucine-rich) repeats. Contains 1 LRRCT domain.
Histone binding is mediated by the concave surface of the LRR region.
Some glutamate residues are glycylated by TTLL8. This modification occurs exclusively on glutamate residues and results in a glycine chain on the gamma-carboxyl group.
Nucleus. Accumulates in the nuclei at the S phase and Cytoplasm. Lacks a nuclear localization signal.